Big Data, Development and Pharma Companies - Clinical Research Informer

New podcast on the future for genomics and big data

Drug Discovery World

AUGUST 3, 2023

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, They are called “ What’s the next step in big data and AI? ” Listen here: The post New podcast on the future for genomics and big data appeared first on Drug Discovery World (DDW).

Big Data

Big Data Genome Genomics Pharma Companies

What lies in the future for genomics and big data?

Drug Discovery World

AUGUST 3, 2023

This is the latest episode of the free DDW narrated podcast, “What lies in the future for genomics and big data?”, They are called “ What’s the next step in big data and AI? ” Listen here: The post What lies in the future for genomics and big data? appeared first on Drug Discovery World (DDW).

Big Data

Big Data Genome Genomics Pharma Companies

What’s the next step in big data and AI?

Drug Discovery World

JULY 18, 2022

Big data and AI are all the rage. But, beyond these buzzwords and the quantity of data, what’s next for these powerful tools? His work provides insight into AI and big data in relation to pharma and drug discovery– now and in the future. Up front collection and controlling your data! Key opportunties.

Big Data

Big Data Life Science Development Clinical Trials

AI continues to gain momentum in the biopharmaceutical industry in 2023

Pharmaceutical Technology

JANUARY 16, 2023

The report also suggested that Big Data was thought to be the most important partner to AI, in terms of introducing technology-related changes in the pharmaceutical sector (Figure 2). In addition to collaborating with AI-technology providers, pharma companies are also engaging in vertical integration.

Big Data

Big Data Pharma Companies Clinical Trials Clinical Trials

Digitalising drug discovery

pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,

Bioinformatics

Bioinformatics Drugs Genome Genomics

Meet the Researcher: Nicola McCarthy, Milner Therapeutics Institute

Drug Discovery World

JULY 3, 2024

NM: So, what we’re interested in the Milner is basically partnering between pharma and academia. We have a big consortium agreement that, at the moment, involves 14 pharma companies. It’s a way of pharma being able to dip their toes in new areas and de-risking from that point of view.

Research

Research Big Data Gene Drugs

Vodcast: Nicola McCarthy, Milner Therapeutics Institute, at SLAS 2024

Drug Discovery World

JULY 3, 2024

NM: So, what we’re interested in the Milner is basically partnering between pharma and academia. We have a big consortium agreement that, at the moment, involves 14 pharma companies. It’s a way of pharma being able to dip their toes in new areas and de-risking from that point of view.

Big Data

Big Data Gene Nurses RNA

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

Clinical Trials

Clinical Trials Clinical Trials Trials Engineer

The DDW Podcast: 2023 in review

Drug Discovery World

DECEMBER 27, 2023

Developing. Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. DDW Highlights Innovative. Listen here. Listen here.

Clinical Trials

Clinical Trials Clinical Trials Drugs Development

The new technologies strengthening pharmaceutical supply chains

Pharmaceutical Technology

NOVEMBER 9, 2022

According to a recent GlobalData report, healthcare professionals have – for the second year in a row – ranked artificial intelligence (AI) and Big Data as the top two technologies revolutionising the pharmaceutical sector. The legacy of this disruption has been a rethink in the way pharma companies do business.

Big Data

Big Data Manufacturing Packaging Packaging

Pioneering access to complex generic products

Drug Discovery World

AUGUST 22, 2023

Originator pharma companies are developing ever more complex products, which are transforming the medical landscape, but their cost places an increasing burden on healthcare budgets worldwide. It could also include specialty products that are harder to develop compared to standard generic products.

Production

Production Bioequivalency In-Vivo In-Vitro

A history of AstraZeneca

pharmaphorum

SEPTEMBER 18, 2020

But although it was dubbed a “dangerous game”, some companies came out on top… On 6th April 1999, two companies with similar science-based cultures and a shared vision of the pharmaceutical industry came together to form what’s now considered as one of the top ten pharma companies in the world: AstraZeneca.

Pharma Companies

Pharma Companies Sales Vaccination Vaccine

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

FEBRUARY 6, 2024

From finding potential active substances and identifying novel targets, to simulating how drugs will function in the human body and optimising laboratory workflows, digital technologies are having a significant impact on drug discovery and development. The company’s platform evaluated more than 11.4

Marketing

Marketing Medicine Genome Genomics

Empowering rare disease patient advocacy organisations with data

pharmaphorum

FEBRUARY 11, 2022

Instead, Komodo’s software is the gateway to the Map’s data. One is the platform, which is essentially what our internal solution developers capitalise on, and then we externalise that capability to third-party developers.”. The business of data. Our software is deployed across two dimensions. About the author.

Life Science

Life Science Engineer Development Big Data

Using technology to reassess the clinical trial landscape

pharmaphorum

MAY 30, 2022

Many companies realise traditional clinical trial processes need modification to improve efficiency, and partnerships are forming in distinct ways to evaluate how digital therapeutics, such as VR can enhance trial designs and outcomes. He oversees operations, including business development, sales and marketing, and people.

Clinical Trials

Clinical Trials Clinical Trials Trials Big Data

5 Top Emerging Pharmacovigilance Startups Impacting The Industry

Cloudbyz

SEPTEMBER 25, 2020

HEPAprint, MEDIKURA, Navro, Embleema & Cloudbyz develop 5 top solutions to watch out for. Our Innovation Analysts recently looked into emerging technologies and up-and-coming startups working on solutions for the pharma sector. Clinical trials play a pivotal role in drug development. HEPAprint – Adverse Drug Reaction (ADR).

Pharma Companies

Pharma Companies Big Data Drugs Clinical Trials

Creating an effective patient engagement set of practices that is enduring and future-proof

pharmaphorum

DECEMBER 22, 2021

The ‘PEP Talks’ monthly e-newsletter has approaching 50 pharma companies as subscribers and the inaugural ‘Patient Engagement Day’ on September 01 st achieved an inspirational number of downloads of toolkits for ways to ‘Amplify the Patient Voice’ as the launch theme. Will pharma listen, and is this even their role to do so?

Clinical Trials

Clinical Trials Clinical Trials Trials Pharma Companies

Ep. 002 – John Mack Podcast Transcript

Pharma Marketing Network

JUNE 11, 2020

And when you look through who those Twitter followers are, it’s very heavily skewed towards industry, as is the website, we’ve also put some tools on our website to be able to look at who the visitors are, by company. Don Langsdorf (EHS): 141 different pharma companies from around the world. John Mack (PG): Yeah.

Marketing

Marketing Branding Regulation Production

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

FEBRUARY 15, 2023

Big data analysis can be enormously powerful in providing insights for business strategy throughout the pharma value chain, including in the acceleration of drug discovery and development, optimization of manufacturing processes, management of supply chains and the creation of innovative sales and marketing strategies.

Big Data

Big Data Manufacturing Production Vaccination

Clinical Research Informer

New podcast on the future for genomics and big data

What lies in the future for genomics and big data?

Trending Sources

What’s the next step in big data and AI?

AI continues to gain momentum in the biopharmaceutical industry in 2023

Digitalising drug discovery

Meet the Researcher: Nicola McCarthy, Milner Therapeutics Institute

Vodcast: Nicola McCarthy, Milner Therapeutics Institute, at SLAS 2024

Synthetic control arms in clinical trials: Making it happen

The DDW Podcast: 2023 in review

The new technologies strengthening pharmaceutical supply chains

Pioneering access to complex generic products

A history of AstraZeneca

How digital innovation is helping therapeutics to get to market faster

Empowering rare disease patient advocacy organisations with data

Using technology to reassess the clinical trial landscape

5 Top Emerging Pharmacovigilance Startups Impacting The Industry

Creating an effective patient engagement set of practices that is enduring and future-proof

Ep. 002 – John Mack Podcast Transcript

Using big data to stabilise pharma supply chains in an age of disruption

Stay Connected